CVM-1118

· TaiRx, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CVM-1118, covering 2025-12-23 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC [Phase 2]

See pricing